OmegaTech Acquires Pharmacia's DHA Tech Rights

July 1, 2000

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


OmegaTech Acquires Pharmacia's DHA Tech Rights

BOULDER, Colo.--OmegaTech Inc. reacquired the rights to production of DHA-rich marine algae. Pharmacia, formerly Monsanto, entered into the agreement with OmegaTech on June 13. As a result of the agreement, OmegaTech will be proceeding with its plans to develop a branded line of DHA GOLD ingredient products, designed for beverage and supplement applications.

"This agreement gives us the opportunity to drive the growth of DHA direct fortification in 11 nutritional product areas, including supplements, infant nutrition, active lifestyle foods and foods that support late adult life," said Mark Braman, OmegaTech's president and chief executive officer.

For more information, visitwww.omegadha.com.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like